OOIR: Observatory of International Research

Papers

(The median citation count of Helicobacter is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	70
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis	56
Issue Information	51
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting	43
UreBimmunodominant epitope‐specificCD8⁺T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals	43
Second‐ and Third‐Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013–2023 of the European Registry on	42
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer	41
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs	41
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection	37
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China	37
Expansion of cagA Copy Number in Helicobacter pylori During Co‐Infection in a Mouse Model	36
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis	36
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis	35
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)	35
	33
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up	32
Issue Information	32
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia	31
Roles of Gastric Non‐Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review	30
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro	30
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”	29
Droplet Digital PCR ‐Based Detection of Clarithromycin Resistance on Rapid Urease Test Samples Predicts	29
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study	26
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	26
Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship	25

Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial	24
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis	24
Perspectives from recent advances of Helicobacter pylori vaccines research	22
Issue Information	22
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin	21
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	20
Development and Evaluation of a Multi‐Epitope Vaccine Based on P22 Virus‐Like Particles Targeting Helicobacter pylori	20
	20
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori‐Infected Peptic Ulcer Children in Vietnam	20
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis	20
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia	20
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial	19
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Er	19
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development	19
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia	19
Assessing the Capabilities of Novel Open‐Source Artificial Intelligence—DeepSeek in Helicobacter pylori‐Related Queries	18
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial	18
Characterization of Fecal Microbial Communities in Patients With Type 2 Diabetes Mellitus Combined With Helicobacter pylori Infection	18
Helicobacter pylori and Impaired Early Childhood Development—Evidence From a Birth Cohort Study From Ghana and Côte d'Ivoire	18
Inquiry about methodology used to isolate multiple Helicobacter pylori strains from the same patient	17
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	17
Effect of Lactobacillus gasseriBIO6369 and Lacticaseibacillus rhamnosusBIO5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection	17
Host Genetic Variants Associated With Helicobacter pylori Infection: A Meta‐Analysis Combined With	17
Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States	17
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis	17
An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model	16
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers	16
Molecular detection of Helicobacter pylori and its genotypic antimicrobial resistance patterns in dyspeptic Mozambican patients	15
The Gastric Microbiota Invade the Lamina Propria in Helicobacter pylori ‐Associated Gastritis and Precancer	15
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori	15
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European stu	15
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy	15
The expression and function of theB7family inHelicobacter pyloriinfection and gastric carcinogenesis process	15
Boosting the Anti‐Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations	15
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months	15
Issue Information	14
Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious	14
Antibiotic Combinations in Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta‐Analysis	14
GM‐CSF as a potential candidate of a vaccine‐induced reduction ofHelicobacter pyloriinfection	14
Age of eradication and failure rates of clarithromycin‐containing triple therapy forHelicobacter pylori: A 15‐year population‐based study	13
Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	13
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target	13
Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis	13
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor	13
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes	13
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori	13
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis	12
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries	12
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug	12
	12

The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response	12
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice	12
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project	11
Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program	11
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence	11
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	11
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection	11
Optimizing Duration and Dosing Frequency of Vonoprazan–Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial	11
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development	11
Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication	11
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention	11
Issue Information	11
Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More E	11
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High‐Dosage L. reuteri in H. pylori	10
	10
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis	10
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study	10
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation	10
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice	10
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals	10
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐CREATE Study	10
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans	10
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review	10
	10
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases	10
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review	9
Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?	9
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review	9
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023	9
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis	9
New insight on the role of Helicobacter pylori cagA in the expression of cell surface antigens with important biological functions in gastric carcinogenesis	9
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells	9
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	9
Epidemiology Helicobacter pylori infection in children in the Tyva Republic (Russia)	8
In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori	8
Artificial Intelligence‐Generated Patient Education Materials for Helicobacter pylori Infection: A Comparative Analysis	8
Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review	8
Knowledge and Practices of Helicobacter pylori Infection Management Among Physicians in Gansu Province, China: A Cross‐Sectional Study	8
Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis	8
Immunoinformatics‐Based Designing of Novel and Potent Multi‐Epitope PSA D15 and Cag11 Immunogens for Helicobacter pylori Immunodiagnostic Assay Development	8
Tracking the Helicobacter pylori Epidemic in Adults and Children in China	8
Atrophic gastritis in Helicobacter pylori‐infected children	8
Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double‐blind, placebo‐controlled trial	7
Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptib	7
Influence of oipA Phase Variation on Virulence Phenotypes Related to Type IV Secretion System in Helicobacter pylori	7
Candidate Antigens and the Development of Helicobacter pylori Vaccines	7
Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori	7
Effect of enhanced patient instructions onHelicobacter pylorieradication: A systematic review and meta‐analysis of randomized controlled trials	7
Gastric mucosal swab as an alternative to biopsy for Helicobacter pylori detection	7
	7
Intravenous metronidazole‐, levofloxacin‐containing triple therapy for treating patients with Helicobacter pylori‐related active peptic ulcer complications: A pilot study	7
	7
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System	7
Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority	7
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea	7
Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp‐EuReg): Results of a Nationwide Survey	7
Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation	7
Impact of mixed‐infection rate of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains on the success rate of clarithromycin‐based eradication treatment	7
First‐Line Therapy for Helicobacter pylori in Slovenia: Data From 2013 to 2023 of the European Registry on H. pylori Management	7
Association betweenHelicobacter pyloriantibodies determined by multiplex serology and gastric cancer risk: A meta‐analysis	6
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta‐analysis	6
Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head‐To‐Head Comparison of Lateral Flow and Enzyme‐Linked Immunosorbent Assays	6
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma	6
Issue Information	6
Helicobacter pylori virulence genotypes in Bogotá River and wastewater treatment plants in Colombia	6
A case of neonatal thrombocytopenia due to maternal Helicobacter pylori‐associated immune thrombocytopenia	6
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	6
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study	6
Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	6
Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study	6
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis	6
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study	6
Issue Information	6
Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome	5
Issue Information	5
Helicobacter pylori regulated microRNA map of human gastric cells	5
Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study	5
REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020	5
Gastric Cancer Screening: Intention to Adhere and Patients' Perspective	5
	5

Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing	5
Treatment failure is a key factor in the development of Helicobacter pylori resistance	5
Helicobacter pyloriresults in lysis and death after exposure to water	5
	5
	5
Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial	5
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	5
Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	5
	5
Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?	5
Two novel sequence types of Helicobacter pylori strains: The first report from Turkey	5
Combatting Helicobacter pylori: A Focus on Nanomaterials	5
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection	5
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article	5
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	5
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	5
Incidence of Gastric Cancer and Neuroendocrine Tumors in Autoimmune Gastritis: A Systematic Review and Meta‐Analysis of Follow‐Up Studies	5
Galangin Alleviates Helicobacter pylori Gastritis Through TLR2 Inhibition and Modulation of the	5
Helicobacter pylori and Colorectal Cancer: Meeting Sir Austin Bradford Hill's Causality Criteria	5
	5
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study	5
Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources	4
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy	4
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	4
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran	4
The Optimal Age of Helicobacter pylori Screen‐and‐Treat for Gastric Cancer Prevention in the United States	4
Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	4
Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐l	4
Incidence of gastrointestinal malignancies increases in persons received eradication therapy for Helicobacter pylori: A cohort study	4
Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Rando	4
Extracellular vesicles from helicobacter pylori‐infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis	4
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis	4
Correction to “Long‐Term Effects of Fecal Microbiota Transplantation on Gut Microbiota After Helicobacter pylori Eradication With Bismuth Quadruple Therapy: A Randomized Controlled Trial”	4
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing	4
Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection	4
Efficacy of Bismuth Therapy in Eradicating Helicobacter pylori in Children—Data From the RENIHp Registry	4
Long‐term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial	4
Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review	4
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predomi	3
Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial	3
The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐Helicobacter pylori treatment in real‐world clinical practice	3
Antimicrobial‐resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018–2020	3
Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial	3
Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta‐Analysis	3
Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial	3
GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection	3
	3
Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, Italy	3
Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials	3
Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection	3
Antibiotic resistance, heteroresistance, and eradication success ofHelicobacter pyloriinfection in children	3
Prevalence of multidrug‐resistant Campylobacter species in wastewater effluents: A menace of environmental and public health concern	3
Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real‐World Evidence Study	3
TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis	3
Achieving Helicobacter pylori eradication in the primary treatment requires a deep integration of personalization and standardization	3
The association between Helicobacter pylori and gastrointestinal disorders during pregnancy: A Multicenter retrospective study	3
Issue Information	3
	3
Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis	3
Overall and Stratified Accuracies of H. pylori Serology Testing: A Multicenter Study of 8497 Screening‐Naïve Adults	3
Vonoprazan‐amoxicillin dual therapy versus bismuth‐containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis	3
	3
Helicobacter pylori induces urease subunit B‐specific CD8⁺ T cell responses in infected individuals via cytosolic pathway of cross‐presentation	3
Lipidome Characterization Reveals Alterations of Fatty Acid Metabolism in Helicobacter pylori Infection	3
Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis	3
Artificial Intelligence in Endoscopy for Predicting Helicobacter pylori Infection: A Systematic Review and Meta‐Analysis	3
Cover Image	3
Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa	3